Sandy Spring Bank’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sandy Spring Bank’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$5K	–	1177
2021 Q1	$5K	Hold	200	–	–	﹤0.01%	887
2020 Q4	$5K	Hold	200	–	–	﹤0.01%	836
2020 Q3	$8K	Hold	200	–	–	﹤0.01%	709
2020 Q2	$10K	Hold	200	–	–	﹤0.01%	700
2020 Q1	$13K	Hold	200	–	–	﹤0.01%	640
2019 Q4	$25K	Hold	200	–	–	﹤0.01%	578
2019 Q3	$13K	Hold	200	–	–	﹤0.01%	693
2019 Q2	$16K	Sell	200 -100	-33%	-$8.95K	﹤0.01%	655
2019 Q1	$34K	Buy	300 +100	+50%	+$10.9K	﹤0.01%	501
2018 Q4	$20K	Hold	200	–	–	﹤0.01%	574
2018 Q3	$25K	Hold	200	–	–	﹤0.01%	563
2018 Q2	$17K	Hold	200	–	–	﹤0.01%	609
2018 Q1	$12K	Hold	200	–	–	﹤0.01%	672
2017 Q4	$12K	Buy	200 +100	+100%	+$6.31K	﹤0.01%	667
2017 Q3	$6K	Buy	+100	New	+$10.8K	﹤0.01%	731

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Sandy Spring Bank's ICPT Position: Q2 2021 in Review

Sandy Spring Bank sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2021, closing a stake of 200 shares — an estimated $5K sold.

Sandy Spring Bank first reported a position in ICPT in Q3 2017 and held it in 15 quarters. The position peaked at $34K in Q1 2019. 129 funds tracked by Wall St. Rank hold ICPT as of Q2 2021.

Sandy Spring Bank reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Sandy Spring Bank sold 200 Intercept Pharmaceuticals, Inc. shares in Q2 2021, an estimated $5K.
Sandy Spring Bank first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2017 and held it in 15 quarters.
Sandy Spring Bank's Intercept Pharmaceuticals, Inc. position peaked at $34K in Q1 2019.
129 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2021.

Based on Sandy Spring Bank's 13F filing for Q2 2021, filed 9 Aug 2021.